Diversified Healthcare Trust (NASDAQ:DHC) Shares Down 5.4% – Here’s Why

Diversified Healthcare Trust (NASDAQ:DHC)’s share price was down 5.4% on Friday . The stock traded as low as $2.52 and last traded at $2.54. Approximately 1,314,695 shares were traded during trading, an increase of 37% from the average daily volume of 961,990 shares. The stock had previously closed at $2.68.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered Diversified Healthcare Trust from a “hold” rating to a “sell” rating in a research note on Wednesday, February 26th.

Diversified Healthcare Trust Stock Down 8.6 %

The company has a market cap of $591.12 million, a price-to-earnings ratio of -1.52 and a beta of 2.15. The business has a fifty day moving average of $2.50 and a two-hundred day moving average of $2.83. The company has a current ratio of 11.57, a quick ratio of 11.57 and a debt-to-equity ratio of 1.44.

Diversified Healthcare Trust (NASDAQ:DHC) last released its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.31. The company had revenue of $379.62 million for the quarter, compared to analyst estimates of $370.97 million. Diversified Healthcare Trust had a negative return on equity of 17.55% and a negative net margin of 26.09%.

Diversified Healthcare Trust Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, February 20th. Shareholders of record on Monday, January 27th were given a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 1.63%. The ex-dividend date of this dividend was Monday, January 27th. Diversified Healthcare Trust’s dividend payout ratio is currently -2.60%.

Institutional Trading of Diversified Healthcare Trust

A number of institutional investors and hedge funds have recently bought and sold shares of DHC. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Diversified Healthcare Trust by 41.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 384,477 shares of the real estate investment trust’s stock worth $884,000 after buying an additional 112,701 shares during the period. Union Square Park Capital Management LLC boosted its holdings in Diversified Healthcare Trust by 32.1% in the fourth quarter. Union Square Park Capital Management LLC now owns 925,000 shares of the real estate investment trust’s stock valued at $2,128,000 after purchasing an additional 225,000 shares in the last quarter. State of Wyoming increased its stake in Diversified Healthcare Trust by 15.2% in the fourth quarter. State of Wyoming now owns 54,284 shares of the real estate investment trust’s stock valued at $125,000 after purchasing an additional 7,175 shares during the last quarter. Southport Management L.L.C. raised its holdings in Diversified Healthcare Trust by 20.0% during the fourth quarter. Southport Management L.L.C. now owns 90,000 shares of the real estate investment trust’s stock worth $207,000 after purchasing an additional 15,000 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. lifted its position in shares of Diversified Healthcare Trust by 133.1% during the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 44,864 shares of the real estate investment trust’s stock worth $103,000 after buying an additional 25,614 shares during the last quarter. 75.98% of the stock is currently owned by hedge funds and other institutional investors.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.